Skip to main content Help with accessibility Skip to main navigation

All Guidance

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 31 - August - 2018
BNF chapter: Endocrine system
Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2018
BNF chapter: Endocrine system
Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2018
BNF chapter: Endocrine system
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 14 - June - 2022
BNF chapter: Endocrine system

Advanced hormone-dependent prostate cancer with spinal metastases - to be read in conjunction with the SPC

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - April - 2018

Denosumab 60mg injection - Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture and treatment of bone loss
associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - February - 2018

Denosumab as a second-line treatment option for the prevention of Osteoporotic Fragility Fractures

Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - May - 2017
BNF chapter: Endocrine system

The purpose of this guideline is to assist primary care practitioners to advise patients of the appropriate monitoring regimen for their clinical condition and diabetes type and to ensure appropriate volumes of testing strips are supplied.

Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - June - 2016
BNF chapter: Endocrine system

This information sheet has been produced to summarise key information about insulin Toujeo for those providing care for patients on this insulin, including on-going prescribing, supply or administration. It is not specifically intended for diabetes specialists who are responsible for initiation and switching to/from insulin Toujeo®. Specialists are advised to refer to the SPC and local protocols for further information.

Pending
Adopted
Adopted
Pending
Adopted
Adopted
Pending
Pending
Date Posted: 19 - March - 2021
BNF chapter: Endocrine system

Please note: GPs and other primary care prescribers are under no obligation to act upon the advice issued by a private specialist. If the NHS prescriber receiving the request does not believe they have the competence to initiate or continue the recommended intervention a referral to an appropriate NHS specialist should be made. Patients are entitled to receive additional private care if this is provided separately from NHS care.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - November - 2018
BNF chapter: Endocrine system

For hypogonadism due to testosterone deficiency in adult men

Indication (licensed):Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

 

Pending
Adopted
Pending
Pending
Adopted
Pending
Adopted
Pending
Date Posted: 15 - August - 2022
BNF chapter: Endocrine system

Unlicensed indication: As supplementation for postmenopausal women with low sexual desire if HRT alone is not effective.

***Please note: the shared care guideline for the use of testosterone by postmenopausal women with low sexual desire has been clinically approved by LSCMMG. In the absence of a commissioned service, it is for individual prescribers to assess their own competence to work to the shared care, that appropriate specialist initiation has occurred and that appropriate risk assessments have been undertaken. Please contact mlcsu.medicinesmanagement@nhs.net for further information***

Further patient information is available via the RCOG menopause hub:
https://www.rcog.org.uk/for-the-public/menopause-and-later-life/
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - July - 2019
BNF chapter: Endocrine system

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - July - 2019
BNF chapter: Endocrine system

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence